Intermolecular stockholders approve acquisition by Merck
Merck announced that its proposed transaction with Intermolecular, Inc. was approved by the stockholders of Intermolecular at a special meeting held on July 17, 2019. On May 6, 2019, Merck had signed a definitive agreement to acquire Intermolecular through a subsidiary for $1.20 per share i ... more
Versum Stockholders Approve Acquisition by Merck
Merck announced that its transaction with Versum Materials, Inc. was approved at a special meeting of Versum’s stockholders. On April 12, 2019, Merck had signed a definitive agreement to acquire Versum for US$53 per share in cash.
“We are pleased that Versum stockholders have voted in favor ... more
Merck and Rigaku Form Partnership to Develop Novel Molecular Structure Analysis Technology
Merck and Rigaku Corp., Tokyo, Japan, have signed a joint development agreement to develop lab consumables based on crystalline sponge technology, which determines the absolute chemical structure of organic molecules and enables X-ray crystallography without crystallization of the analyte. ... more